Would you be interested in the Business Strategies, Competitive Strengths and Key Risks?

Log in or Become a UTRADE Client Now

Latest IPO

Competitive Margin Interest Rates $0 Handling Fee on Cash Applications for New Self-Serviced Clients # Login to Subscribe
Planned Offering Offering Closing Date Settlement Refund / Grey Market Trading
2021

AUG
0607080910111213141516171819202122232425
IPO Calendar
Planned IPOs
Stock Offer Period Trading Price（HKD） BoardLot IndicativeInterest Rate UOBKH'sClosing Date Sponsor(s) Oversubscription
IPO Calendar
 2015Li Auto - W 03/08/202106/08/2021 12/08/2021 150.0150.0 100 1.60% 05/08/2021

Goldman Sachs

CICC

Day 1：>1.13x

Day 2：>1.57x

Day 3：>2.27x
Planned IPOs *
[Planned]
Cloud Village Passed PHIP on 1 Aug N/A N/A N/A N/A N/A

BofA*

CICC*

Credit Suisse*

 -
[Planned]
AInnovation Application Submitted* N/A N/A N/A N/A N/A

UBS*

CICC*

China Renaissance*

 -
[Planned]
Imeik Technology Dev N/A Aug* N/A N/A N/A N/A

Morgan Stanley*

CICC*

 -
[Planned]
HeartCare Medical Passed PHIP on 25 Jun N/A N/A N/A N/A N/A

Goldman Sachs*

CITIC*

 -
[Planned]
Edding Group Passed PHIP on 25 Jun N/A N/A N/A N/A N/A

Morgan Stanley*

Credit Suisse*

 -
[Planned]
Acotec Scientific Passed PHIP on 23 Jun N/A N/A N/A N/A N/A

Morgan Stanley*

CICC*

 -
[Planned]
Transcenta Passed PHIP on 22 Jun N/A N/A N/A N/A N/A

Goldman Sachs*

CICC*

 -
[Planned]
Shanghai Bio-heart Biological Technology Passed PHIP on 16 Jun N/A N/A N/A N/A N/A

Goldman Sachs*

Huatai*

 -
[Planned]
eBeauty Passed PHIP on 23 Jun N/A N/A N/A N/A N/A

CITIC*

Credit Suisse*

 -
[Planned]
Gu Sheng Tang N/A 2021* N/A N/A N/A N/A

BofA*

Haitong*

 -
[Planned]
China Duty Free Group Application Submitted* Q4* N/A N/A N/A N/A

N/A

 -
[Planned]
MicroPort MedBot Application Submitted* 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
SenseTime N/A End of 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
Chief Group Application Submitted* N/A N/A N/A N/A N/A

BOCOM*

 -
[Planned]
Konew Financial N/A N/A N/A N/A N/A N/A

CCBI*

 -
[Planned]
LexinFintech N/A 2nd half of year* N/A N/A N/A N/A

N/A

 -
[Planned]
Top Glove N/A Q3* N/A N/A N/A N/A

CICC*

 -
[Planned]
RF China Application Submitted* Q3* N/A N/A N/A N/A

ABCI*

CICC*

 -
[Planned]
Fangzhi Group Application Submitted* N/A N/A N/A N/A N/A

CCBI*

 -
[Planned]
Wanda Group Sep* N/A N/A N/A N/A N/A

N/A

 -
[Planned]
DRC Bank N/A Q3* N/A N/A N/A N/A

CMS*

CMBI*

ABCI*

ICBC*

 -
[Planned]
TamJai INTL Application Submitted* N/A N/A N/A N/A N/A

N/A

 -
[Planned]
Hanyu Medical Application Submitted* Q3* N/A N/A N/A N/A

CITIC*

Citi*

 -
[Planned]
XiaoDian N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
GOGOX N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
Qdama N/A N/A N/A N/A N/A N/A

N/A

 -
[Planned]
Medbanks N/A 2nd half of the year* N/A N/A N/A N/A

Morgan Stanley*

CICC*

Haitong*

 -
[Planned]
ESCO N/A Q4* N/A N/A N/A N/A

N/A

 -
[Planned]
APM Ｍonaco N/A 2021* N/A N/A N/A N/A

Morgan Stanley*

CICC*

 -
[Planned]
Abbisko N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
NIO N/A 2021* N/A N/A N/A N/A

Credit Suisse*

Morgan Stanley*

 -
[Planned]
YiSheng Biopharma Application Submitted* 2021* N/A N/A N/A N/A

Morgan Stanley*

Haitong*

 -
[Planned]
Novotech N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
ECARX N/A 2nd half of the year* N/A N/A N/A N/A

Morgan Stanley*

UBS*

 -
[Planned]
Weibo N/A 2nd half of the year* N/A N/A N/A N/A

Goldman Sachs*

UBS*

CLSA*

 -
[Planned]
Betta Pharmaceuticals Passed PHIP on 30 May N/A N/A N/A N/A N/A

Goldman Sachs*

UBS*

CITIC*

 -
[Planned]
Visen Pharma N/A 2021* N/A N/A N/A N/A

Jefferies Group*

Morgan Stanley*

 -
[Planned]
Recbio N/A 2021* N/A N/A N/A N/A

N/A

 -
[Planned]
Tencent Music N/A This Year* N/A N/A N/A N/A

Morgan Stanley*

JPMorgan*

 -
[Planned]
JOYY N/A Q3* N/A N/A N/A N/A

N/A

 -
[Planned]
Vipshop N/A Q2* N/A N/A N/A N/A

N/A

 -
[Planned]
DIDA CHUXING N/A N/A N/A N/A N/A N/A

Haitong*

Nomura*

 -
[Planned]
DiDi N/A Q3* N/A N/A N/A N/A

Goldman Sachs*

 -
[Planned]
WeDoctor Application Submitted* 1st half of the year* N/A N/A N/A N/A

Citibank*

CMB INTL*

JPM*

Credit Suisse*

CITIC*

 -

# Terms and Conditions Apply

*Market News

：UOB Kay Hian (UOBKH) is one of the participants

Copyright ©, UOB Kay Hian (Hong Kong) Ltd. All rights reserved. Securities & Futures Commission Registered: CE Number AAW261 Client Agreement-Terms & Conditions ( Securities / Futures )